INNOVATIVE STRATEGIES FOR THE PREVENTION, DIAGNOSIS AND THERAPY OF RESPIRATORY DISEASES INDUCED BY AMBROSIA POLLEN (Q3099176): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
| Property / beneficiary: Q3118623 / rank | |||
Normal rank | |||
Revision as of 16:27, 23 September 2021
Project Q3099176 in Romania
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | INNOVATIVE STRATEGIES FOR THE PREVENTION, DIAGNOSIS AND THERAPY OF RESPIRATORY DISEASES INDUCED BY AMBROSIA POLLEN |
Project Q3099176 in Romania |
Statements
7,158,098.805 Romanian Leu
0 references
8,477,610.1 Romanian Leu
0 references
0.84 percent
0 references
9 September 2016
0 references
8 December 2020
0 references
SPITALUL CLINIC JUDETEAN DE URGENTA " PIUS BRINZEU " TIMISOARA
0 references
Obiectivul principal al proiectului INSPIRED este dezvoltarea unui nou kit de diagnostic bazat pe utilizarea alergenelor recombinate, specific pentru pacienții alergici la ambrozia, care va orienta mai bine terapia bolii, realizat cu sprijinul unei echipe internaționale, prin atragerea de specialiști din străinătate cu competență recunoscută, crescând astfel participarea României în domeniile de cercetare la standarde europene și crearea unui nucleu de competenţă ştiinţifică de înalt nivel în aplicarea tehnologiilor avansate bazate pe alergene recombinate, în cadrul Centrului de cercetare OncoGen – noua infrastructură a Spitalului Clinic Județean de Urgență ”Pius Brânzeu” Timișoara, finanțat din fonduri structurale acordate prin POS CCE 2007-2013 România. (Romanian)
0 references
The main objective of the INSPIRED project is the development of a new diagnostic kit based on the use of recombinant allergens, specific for patients allergic to ambrosia, which will better guide disease therapy, achieved with the support of an international team, by attracting specialists from abroad with recognised competence, thus increasing Romania’s participation in research fields at European standards and creating a core of high-level scientific competence in the application of advanced technologies based on recombinant allergens, within the OncoGen Research Center – the new infrastructure of the Emergency Clinical Hospital “Pius Brânzeu” Timisoara, financed from structural funds granted through SOP CCE 2007-2013 Romania. (English)
16 September 2021
0 references
Municipiul Timişoara, Romania
0 references
Identifiers
103663
0 references